- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Ruxolitinib – July 2016
Ruxolitinib: 10 mg tablet, 56, Jakavi®
Last updated
28 October 2016